Hematological malignancies during pregnancy (Review)

  • Authors:
    • Merav Barzilai
    • Irit Avivi
    • Odelia Amit
  • View Affiliations

  • Published online on: November 8, 2018     https://doi.org/10.3892/mco.2018.1759
  • Pages: 3-9
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Hematological malignancy during pregnancy is a rare event, therefore most data on this issue is based on case studies, retrospective studies and expert opinion. The purpose of the present narrative review was to provide an overview of the diagnosis and recommended management of the most common hematological malignancies during pregnancy, based on current literature, with clinical cases, and discussion of the diagnostic and therapeutic options. The therapeutic consensus while coping with hematological malignancies in pregnancy is to salvage the mother, while trying to preserve pregnancy and avoid treatment‑related‑toxicity to the fetus. In most scenarios, particularly during late trimesters, the goal is to administer the same treatment as outside of pregnancy, if possible. Further research is needed for better evidence‑based management.
View References

Related Articles

Journal Cover

January 2019
Volume 10 Issue 1

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Barzilai, M., Avivi, I., & Amit, O. (2019). Hematological malignancies during pregnancy (Review). Molecular and Clinical Oncology, 10, 3-9. https://doi.org/10.3892/mco.2018.1759
MLA
Barzilai, M., Avivi, I., Amit, O."Hematological malignancies during pregnancy (Review)". Molecular and Clinical Oncology 10.1 (2019): 3-9.
Chicago
Barzilai, M., Avivi, I., Amit, O."Hematological malignancies during pregnancy (Review)". Molecular and Clinical Oncology 10, no. 1 (2019): 3-9. https://doi.org/10.3892/mco.2018.1759